Frederick S. Longer specializes in representing individuals who have been harmed by dangerous drugs, medical devices, other defective products and antitrust violations.

Mr. Longer has extensive experience in prosecuting individual, complex and class action litigations in both state and federal courts across the country. Mr. Longer has been involved in the resolution of several of the largest settlements involving personal injuries including the $6.75 Billion settlement involving Diet Drugs and the $4.85 Billion settlement involving Vioxx. Mr. Longer was part of the teams responsible for negotiating the settlements in the National Football League Players’ Concussion Litigation, MDL No. 2323, the Chinese-Manufactured Drywall Products Liability Litigation, MDL 2047, involving various suppliers and manufacturers of Chinese Drywall valued in excess of $1 Billion, and the landmark environmental settlements with DuPont and 3M in the In Re Aqueous Film-Forming Foams Products Liability Litigation, MDL No. 2873, valued in excess of $12 Billion.

Mr. Longer has a wealth of experience in mass torts and has frequently been the chairman or member of the Law and Briefing Committee in numerous multi-district litigations in In re Propulsid Products Liability Litigation, MDL No. 1355 (E.D. La.); In re Rezulin Products Liability Litigation, MDL No. 1348 (S.D.N.Y.); In re Vioxx Products Liability Litigation, MDL No. 1657 (E.D.La.); In re Orthopedic Bone Screw Products Liability Litigation, MDL No. 1014 (E.D. Pa.); In re Diet Drug Litigation, MDL No. 1203 (E.D. Pa.); In re Xarelto Products Liability Litigation, MDL No. 2592 (E.D.La.); In Re: Zantac (Ranitidine) Products Liability Litigation, MDL No. 2924; and In Re Aqueous Film-Forming Foams Products Liability Litigation, MDL No. 2873.

Mr. Longer is a frequent lecturer and has presented numerous seminars on various legal topics for professional groups. Some of Mr. Longer’s speaking engagements include Mass Torts Made Perfect, A Brief Update on Preemption (October 2018); The Collaboration for Research Integrity and Transparency (Yale Law School September 2018); Strafford Webinar, “No Injury” and “Overbroad” Consumer Class Actions: Strategies to Pursue or Defendant Class Certification (October 2015); Harris Martins’ MDL Conference, Current Issues in Multi-district Litigation Practice (September 26, 2011); Mass Torts Made Perfect, FDA Preemption: Is this the end? (May 2008). He has authored numerous articles including ABA, Service of Process in China (April 2012); Trial, The Federal Judiciary’s Super Magnet (July 2009). He was also featured in Herbert J. Stern and Stephen A. Saltzburg, Trying Cases to Win: Anatomy of a Trial (Aspen 1999).

Representative Reported Cases:

• Byrd v. Aaron’s Inc., 784 F.3d 154 (3d Cir. 2015)
• Mulcahey v. Columbia Organic Chemicals Co., 29 F.3d 148 (4th Cir. 1994)
• Levy v. Jannetta, 621 A.2d 585 (Pa.Super. 1992)
• Mallory v. Norfolk S. Ry. Co., 600 U.S. 122 (2023)

Mr. Longer has received Martindale-Hubbell’s highest rating (AV) as a pre-eminent lawyer for his legal ability and ethical standards. He has also been recognized by his peers as a Super Lawyer since 2008.

AV Peer Review Rated.